Abstract:BACKGROUND: The plasma level of neuron specific enolase (NSE) can be used to diagnose and evaluate neuronal injury and predict early prognosis. OBJECTIVE: To observe the dynamic changes in plasma levels of NSE in patients with acute cerebral infarction, and to investigate its correlations with disease severity and prognosis. DESIGN, TIME AND SETTING: This non-randomized, concurrent case-control experiment was performed at the Department of Neurology, First Hospital Affiliated to Heilongjiang University of Traditional Chinese Medicine between May and July 2007. PARTICIPANTS: Eighteen patients with acute cerebral infarction, who received treatment at the Department of Neurology, First Hospital Affiliated to Heilongjiang University of Traditional Chinese Medicine between May and July 2007, were recruited into the patient group. An additional 10 healthy individuals, who received health examinations simultaneously, were included as controls. METHODS: Following admission (within 3 days) and at days 6, 12, and 30 subsequent to acute cerebral infarction attack, 3 mL venous blood was taken from each patient before the morning meal to determine the plasma level of NSE by enzyme-labeled immunosorbent assay. One-time blood extraction was performed in each healthy subject during the health examination for the same purpose as in patients. At 6 and 30 days following acute cerebral infarction attack, CT examination was performed for calculation of cerebral infarction volume according to the Tada formula. Following admission and at 30 days of disease invasion, all patients were scored by the National Institutes of Health Stroke Scale (NIHSS, 13 items). MAIN OUTCOME MEASURES: Comparison of NSE plasma level between acute cerebral infarction patients and healthy individuals; correlations of NSE plasma level in acute cerebral infarction patients with cerebral infarction volume, NIHSS score, and prognosis. RESULTS: Following admission and at days 6 and 12 of disease invasion, the plasma level of NSE was significantly higher in the patient group than in the control group (P < 0.05). Following admission and at day 30 of disease invasion, the NIHSS scores of the patient group were 17.706 and 11.222, respectively. Following admission and at day 6 of disease invasion, the plasma level of NSE was positively correlated with cerebral infarction volume (r = 0.503, 0.435, P < 0.05), but it was negatively correlated with NIHSS score (r = -0.571, 0.368, P < 0.05). The plasma level of NSE was mostly correlated with cerebral infarction volume, followed by NIHSS score, and lastly prognosis, with regression coefficients of 0.386, 0.343, and 0.340, respectively. CONCLUSION: The plasma level of NSE is higher in patients with acute cerebral infarction than in the healthy population. It can reflect infarct severity and predict early prognosis of acute cerebral infarction.

Clinical Significance of Neuron Specific Enolase and S100 Beta Protein in Intracranial Infection and Brain Injury.

High S100B Levels in Cerebrospinal Fluid and Peripheral Blood of Patients with Acute Basal Ganglial Hemorrhage Are Associated with Poor Outcome.

Expression of S100B Protein Levels in Serum and Cerebrospinal Fluid with Different Forms of Neuropsychiatric Systemic Lupus Erythematosus.

Serum S100β is a Better Biomarker Than Neuron-Specific Enolase for Sepsis-Associated Encephalopathy and Determining Its Prognosis: A Prospective and Observational Study

Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury

876 Neuron Specific Enolase and S-100 Protein in Sepsis Associated Encephalopathy (SAE)

The Diagnostic Value of Neuron-Specific Enolase, Central Nervous System Specific Protein and Interleukin-6 in Sepsis-Associated Encephalopathy

S-100B and Neuron Specific Enolase in Outcome Prediction of Severe Head Injury

Expression and clinical significance of NSE and IGF-Ⅰ in cerebrospinal fluid of pediatric patients with central system infections

Significance of serum neuron-specific enolase in assessment of severity of brain damage and its correlation with Glascow Coma Scale score

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity

Meta-analysis of evaluating neuron specific enolase as a serum biomarker for sepsis-associated encephalopathy

Clinical value of serum neuron-specific enolase in sepsis-associated encephalopathy: a systematic review and meta-analysis

Elevation of neuron-specific enolase and S-100β protein level in experimental acute spinal cord injury

Serum Neuron Specific Enolase and Matrix Metalloproteinases in Patients with Severe Traumatic Brain Injury and the Clinical Significance

Diagnostic and prognostic value of serum S100B in sepsis-associated encephalopathy: A systematic review and meta-analysis

Diagnostic and Prognostic Values of S100B versus Neuron Specific Enolase for Traumatic Brain Injury; a Systematic Review and Meta-analysis

The Prognostic Value of Serum Neuron Specific Enolase (NSE) and S100B Level in Patients of Acute Spinal Cord Injury

Plasma level of neuron specific enolase in patients with acute cerebral infarction:A case-control study

Research of Serum Neuron-specific Enolase to Evaluate the Prognosis of Severe Head Injury